Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
CHARGE-APP
1 other identifier
interventional
480
2 countries
8
Brief Summary
The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Start
First participant enrolled
May 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 27, 2025
February 1, 2025
4.6 years
June 30, 2017
February 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ambulatory Systolic Blood Pressure
Change in ambulatory 24h systolic blood pressure
12 months
Secondary Outcomes (9)
Ambulatory Diastolic Blood Pressure
12 months
Difference between Office Blood Pressure and Home Blood Pressure
12 months
Left ventricular mass index
12 months
Left ventricular hypertrophy
12 months
Urinary albumin to creatinine ratio
12 months
- +4 more secondary outcomes
Study Arms (2)
Group 1 - Usual care
ACTIVE COMPARATORStandard strategy for management of hypertension, based on three-monthly visits at the referral centre.
Group 2 - POST-strategy
EXPERIMENTALPatient Optimal Strategy for Treatment (POST) for management of hypertension, based on on three-monthly visits at the referral centre + providing the patients with the ESH-CARE APP system to communicate home blood pressure measurements to the referral centre, and the referral centre with an online platform to monitor the patients' status.
Interventions
Antihypertensive therapy is adjusted every 3 months on the basis of office blood pressure values.
Antihypertensive therapy is adjusted every 15 days on the basis of home blood pressure values.
Eligibility Criteria
You may qualify if:
- Male and female subjects;
- Age 18-80 years;
- Either the patient or another person close to him/her should possess a smartphone compatible with the ESH CARE app and be capable of using it;
- Uncontrolled (untreated or treated) hypertension, defined as office BP ≥140/90 mmHg, and Ambulatory 24h ABP ≥130/80 mmHg
You may not qualify if:
- eGFR \<45 mL/min/1.73 m2 (CKD-EPI creatinine equation 2009);
- Severe uncontrolled hypertension (i.e. BP ≥200/120 mmHg despite treatment);
- Known secondary hypertension;
- Orthostatic hypotension (SBP fall \> 20 mmHg on standing);
- Unstable clinical conditions or severe disease with short life expectation;
- Known atrial fibrillation;
- Hepatic disease as determined by either AST or ALT values \> 2 times the upper limit of normal;
- History of gastrointestinal surgery or disorders which could interfere with drug absorption
- History of malignancy including leukaemia and lymphoma (but not basal cell skin cancer) within the last 5 years;
- History of clinically significant autoimmune disorders such as systemic lupus erythematosus;
- History of drug or alcohol abuse within the last 5 years;
- History of non-compliance to medical regimens and/or patients who are considered potentially unreliable;
- Dementia (clinical diagnosis);
- Inability or unwillingness to give free informed consent;
- Inability to use even simple communication technologies;
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Private Hospital " Dr Raúl Matera"
Bahía Blanca, B8000, Argentina
Argerich Hospital
Buenos Aires, C155 AHD, Argentina
General San Martin Hospital of La Plata
La Plata, 1900, Argentina
Spanish Hospital of Mendoza
Mendoza, M5501, Argentina
British Sanatorium of Rosario
Rosario, S2000, Argentina
Shanghai Institute of Hypertension
Shanghai, Huangpu, China
Jiangsu Province Official Hospital
Jiangse, 210024, China
Ruijin Hospital North
Shanghai, 200025, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianfranco Parati, MD
Istituto Auxologico Italiano
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Centralized reading of ECG, echocardiography and ABPM, blinded for treatment group assignment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 2, 2017
Study Start
May 11, 2021
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share